- The Oxford–AstraZeneca COVID‑19 vaccine, sold
under the
brand names Covishield and
Vaxzevria among others, is a
viral vector vaccine for the prevention...
-
March 2021, the
Government of
India temporarily froze exports of the
Covishield,
citing India's own
COVID crisis and the
domestic need for
these vaccines...
- (manufactured
under license by
Serum Institute of
India under the
trade name
Covishield) and
Covaxin (a
vaccine developed locally by
Bharat Biotech). They have...
-
contribution in
fighting Covid-19 by
successfully supplying huge
quantities of
Covishield in
India and globally, a
vaccine developed by Oxford-AstraZeneca and produced...
-
conditional use of AstraZeneca's COVID-19
vaccine AZD1222 (marketed as
Covishield).
Covishield is
developed by the
University of
Oxford and its spin-out company...
-
multinational pharmaceutical company AstraZeneca,
which is
developing AZD1222 (
Covishield) in
partnership with the
University of Oxford. It is
reported that Serum...
- "Madras high
court orders actor Mansoor Ali Khan to pay Rs 2 lakh for
Covishield procurement -
Chennai News". The
Times of India. 29
April 2021. Retrieved...
- acknowledged. "ChAdOx1 nCoV- 19
Corona Virus Vaccine (Recombinant) -
Covishield".
Serum Institute Of India.
Archived from the
original on 19
April 2021...
- not be
approved for the
general po****tion. For example, the CoronaVac,
Covishield, BBIBP-CorV and
Covaxin vaccines are not part of Australia's national...
- its
vaccination programme on 16
January 2021 with
AstraZeneca vaccine (
Covishield) and the
indigenous Covaxin. Later,
Sputnik V and the
Moderna vaccine...
